About SOMAÍ
compassionate care scientifically crafted
At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine.
SOMAÍ owns a state-of-the-art manufacturing facility, SOMAÍ Pharmaceuticals, and indoor cultivation, NovaSoma, in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of a few and the first European-based vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.
For patients
FOR HEALTHCARE PROFESSIONALs
For partners
Global Company News
Spain Takes a Major Step Toward Pharmaceutical-Grade Cannabis Regulation: A New Standard for Europe
Spain’s Royal Decree on Medicinal Cannabis is now official, a long-awaited and highly significant move that finally integrates cannabis-based medicines…
Read more
SOMAÍ Adds International Lifestyle Brand Cookies to Global Medical Cannabis Markets
Lisbon, Portugal — [12 November 2025] — Cookies, the most globally recognized cannabis brand, is entering global medical markets with…
Read more
Airo Brands Announces CE-Certified Medical Inhalation Device in Partnership with SOMAÍ
AIRO BRANDS, Inc. (“Airo”), a U.S. multi-state CPG company focused on proprietary cannabis products, in partnership with Jupiter Research LLC,…
Read more
Global Cannabis See-Saw: Surging Demand Meets Tightening Regulations
The global cannabis industry has experienced both great success and significant challenges in 2025. Volumes are surging and new countries…
Read more
Digital Access or Illicit Return? Restricting Telemedicine Could Drive 42% Back to Underground: Industry Insiders Weigh In
“As Germany debates cracking down on tele-clinics and flower sales, all eyes are on patient experience disruptions,” Sassano said.“Reversing course…
Read more
149_Michael Sassano, Master Multi-Country Operator
From Wall Street to Lisbon, from real estate to cannabis pharmaceuticals — Michael Sassano’s journey is anything but ordinary. In this…
Read more
Australia’s White-Label Identity Crisis: A Story of Quality, Branding and Margins
As the medical cannabis industry in Australia continues to boom with more patients than ever and the most modern products…
Read more
The New Era of Cannabis in Switzerland, Open Access and Education Lead B SOMAÍ and Dascoli Pharma Partnership
Switzerland has long been a country that wants to create a safe and sustainable future for its population — and…
Read more
SOMAÍ and Lusófona University Publish Peer-Reviewed Study Showcasing Best Practices in Full-Spectrum Cannabis Oil Production
Lisbon, Portugal — [1 July 2025] — SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specializing in cannabinoid-based medicines,…
Read more
SOMAÍ Launches New HCP Portals and AI Assistant as Part of Global Website Enhancements
SOMAÍ has announced the launch of dedicated HCP portals in Australia, Germany, and the United Kingdom, as well as the…
Read more